BioSpace News Archive

Policy

Moderna and Pfizer: Lawsuits and Charitable Giving on the Agenda

Monday, Moderna told a Delaware federal court that it was immune from patent-infringement charges over the COVID-19 vaccine because it supplied the vaccine for a U.S. government effort.

May 25, 2022
·
3 min read
·
Mark Terry
Drug Development

Global Roundup: Iceland’s Alvotech Hits Mark with Biosimilar to Janssen’s Stelara

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

May 25, 2022
·
7 min read
·
Alex Keown
Job Trends

$2.1B Eli Lilly Expansion to Add 500 New Jobs in Indiana

When the two new sites are up and running, Eli Lilly predicted the project will create up to 500 new jobs - with the expectation of four indirect jobs for each full-time position, based on industry data.

May 25, 2022
·
2 min read
·
Alex Keown
Business

Two Remarkable Women of Takeda’s C-Suite Make the Professional Personal

At the start of Takeda’s fiscal year on April 1, Ramona Sequeira and Julie Kim stepped into new positions on the company’s executive leadership team and became role models for women.

May 25, 2022
·
9 min read
·
Abbey Glasure
Drug Development

Invectys is Pioneering HLA-G Immune Checkpoint Inhibitors in Cancer Therapeutics

Invectys is one of only a few companies investigating HLA-G, a natural immune checkpoint inhibitor, for solid tumors.

May 25, 2022
·
4 min read
·
Gail Dutton
Drug Development

Money on the Move: Biotechs Target Cancers, Dermatology and Strokes

Private investors, governmental institutions and longtime life sciences investors provided funding to develop therapies for cancers, dermatological problems and acute ischemic strokes.

May 25, 2022
·
4 min read
·
Hannah Chudleigh
Policy

Lawsuits Galore: J&J, BMS, GSK, Mylan and Others

Johnson & Johnson and Momenta Pharmaceuticals have filed a patent infringement lawsuit over a generic multiple sclerosis drug developed by India-based Natco, Gland Pharma and Mylan.

May 25, 2022
·
2 min read
·
Alex Keown
Business

Samsung to Invest $356 Billion into Chipmaking, Biopharma

Most of Samsung’s investment will be in South Korea, and it expects to create 80,000 new jobs through 2026, or about 16,000 positions annually.

May 25, 2022
·
2 min read
·
Mark Terry
Business

From Bench to Boardroom, PhD-Wielding Founders Buck Tradition

Today, scientist-founders are likely to remain in charge, shepherding the companies they founded to the next iteration. BioSpace spoke with one such founder, Mammoth Biosciences’ Trevor Martin.

May 25, 2022
·
4 min read
·
Gail Dutton
Business

Terremoto Biosciences gets $75M to Develop Covalent Medicines

San Francisco-based Terremoto Biosciences launched with $75 million in Series A financing from OrbiMed and Third Rock Ventures as it develops highly targeted, small-molecule medicines.

May 25, 2022
·
3 min read
·
Hannah Chudleigh